Originating from Cancer Research Technology, Ximbiois an online portal for the life science community toexchange knowledge and trade reagents. Virtuallydeposit your reagents to raise your profile and share yourresearch globally.
VISIT US ON STAND 209
Mandeep Sehmi and Hugh Spotswood will be representing the Ximbio team at AUTM 2015. We invite technology transfer professionals to speak to us on stand 209 about the benefits of Ximbio.
If you would like to arrange a one-to-one discussion at the event, please contact Mandeep Sehmi (Mandeep@ximb.io)
WHY USE XIMBIO?
Ximbio enables technology transfer offices to increase the return on reagents originating from their institution, while reducing the time and resource required to commercialise low-value items such as antibodies. As a result, reagents that may otherwise not have been commercialised are made available to the wider scientific community.
- Virtually deposit reagents free of charge to a central portal or contract Ximbio to fully manage your reagent portfolio; we act as an extension of your team, arranging licensing deals with life science reagents companies and also offering manufacturing, storage and fulfilment facilities.
- Benefit from Ximbio’s existing relationships with more than 80 life science reagents companies. We provide global visibility of your reagents.
- Link each reagent record to the originating inventor to enable your researchers and institution to be credited for their work.
- Reduce the risk of reagents getting ‘lost’ in laboratories.
“We have created Ximbio to be a place where scientists and Technology Transfer Offices can share their research, and reagents companies can source new products, in a streamlined process." -Melanie Hardman, Head of Ximbio